DJIA 17,122.01 15.31 0.09%
NASDAQ 4,569.62 -1.02 -0.02%
S&P 500 2,000.12 0.10 0.00%
market minute promo

GlaxoSmithKline (NYSE: GSK)

48.67 0.41 (0.85%)

REAL-TIME: Last trade at

Extended Hours: $48.81 $0.14 (0.29%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

GSK $48.67 0.85%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.62
Previous Close $48.26
Daily Range $48.56 - $48.82
52-Week Range $46.01 - $56.73
Market Cap $116.9B
P/E Ratio 16.58
Dividend (Yield) $2.59 (5.5%)
Ex-Dividend Date
Dividend Pay Date
08/06/14
10/02/14
Volume 2,767,175
Average Daily Volume 4,532,117
Current FY EPS $3.20

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary Rss Feed

Should Gilead Sciences, inc. Fear This New Competitor Drug?

GlaxoSmithKline and Pfizer's ViiV have won approval for a new HIV therapy that may work better than Gilead's Atripla.

Benzinga's M&A Chatter for Wednesday August 27, 2014

Growth Prospects Remain Strong For Pfizer

Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade

3 Drugs Stocks On The Rise

Top 3 Yielding Buy-Rated Stocks: PAA, VZ, GSK

Closing Update: Dow, S&P 500 Finish With New Records, Supported by Cyclical Stocks, Positive Data

GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) Indication For Use In Patients Wit

GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) Indication For Use In Patients With Severe Aplastic Anaemia

Sector Update: Health Care Stocks Climbing in Late Trade; Merck Hits 11-Year High After Teaming Up W

Sector Update: Health Care Stocks Climbing in Late Trade; Merck Hits 11-Year High After Teaming Up With Pfizer on Cancer Treatment

4 Foreign Blue-Chip Stocks With 4% Dividend Yields to Buy

See More GSK News...

GSK's Top Competitors

GSK $48.67 (0.85%)
Current stock: GSK
JNJ $103.22 (-0.21%)
Current stock: JNJ
NVS $90.00 (0.32%)
Current stock: NVS
RHHBY $36.63 (0.05%)
Current stock: RHHBY